MariMed Inc. (OTCMKTS:MRMD) Sees Large Decline in Short Interest

MariMed Inc. (OTCMKTS:MRMDGet Free Report) was the target of a significant drop in short interest in the month of August. As of August 31st, there was short interest totaling 16,100 shares, a drop of 66.1% from the August 15th total of 47,500 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 4,684,900 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 4,684,900 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Zacks Research raised shares of MariMed from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, August 13th. Two investment analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, MariMed has a consensus rating of “Strong Buy”.

Get Our Latest Analysis on MariMed

MariMed Stock Down 1.0%

Shares of OTCMKTS:MRMD opened at $0.14 on Friday. The company has a current ratio of 1.12, a quick ratio of 0.36 and a debt-to-equity ratio of 1.25. The stock has a fifty day simple moving average of $0.12 and a two-hundred day simple moving average of $0.10. MariMed has a 12-month low of $0.07 and a 12-month high of $0.23. The stock has a market capitalization of $56.03 million, a price-to-earnings ratio of -4.78 and a beta of 3.01.

About MariMed

(Get Free Report)

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.

See Also

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.